Life Science Big News Roundup: BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate; Kalytera Announces Additional Share Issuance for Services under Payments Agreement with Salzman Group Life Science Investing
Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering Pharmaceutical Investing
SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data Pharmaceutical Investing
Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan Pharmaceutical Investing
Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101 Pharmaceutical Investing
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences Pharmaceutical Investing
Green Growth Brands Solidifies Nevada Market Position with Award of Seven Additional Cannabis Licenses Cannabis Investing News
